A citation-based method for searching scientific literature

Kerstin Rhiem, Dolores Foth, Barbara Wappenschmidt, Heidrun Gevensleben, Reinhard Büttner, Uwe Ulrich, Rita K Schmutzler. Arch Gynecol Obstet 2011
Times Cited: 27







List of co-cited articles
195 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
Timothy R Rebbeck, Henry T Lynch, Susan L Neuhausen, Steven A Narod, Laura Van't Veer, Judy E Garber, Gareth Evans, Claudine Isaacs, Mary B Daly, Ellen Matloff,[...]. N Engl J Med 2002
62

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
Noah D Kauff, Jaya M Satagopan, Mark E Robson, Lauren Scheuer, Martee Hensley, Clifford A Hudis, Nathan A Ellis, Jeff Boyd, Patrick I Borgen, Richard R Barakat,[...]. N Engl J Med 2002
868
51

Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.
Amy Finch, Mario Beiner, Jan Lubinski, Henry T Lynch, Pal Moller, Barry Rosen, Joan Murphy, Parviz Ghadirian, Eitan Friedman, William D Foulkes,[...]. JAMA 2006
394
51

Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol.
C Bethan Powell, Lee-may Chen, Jane McLennan, Beth Crawford, Charles Zaloudek, Joseph T Rabban, Dan H Moore, John Ziegler. Int J Gynecol Cancer 2011
104
48

Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.
Noah D Kauff, Susan M Domchek, Tara M Friebel, Mark E Robson, Johanna Lee, Judy E Garber, Claudine Isaacs, D Gareth Evans, Henry Lynch, Rosalind A Eeles,[...]. J Clin Oncol 2008
359
44

Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy.
C Bethan Powell, Eric Kenley, Lee-May Chen, Beth Crawford, Jane McLennan, Charles Zaloudek, Miriam Komaromy, Mary Beattie, John Ziegler. J Clin Oncol 2005
253
40

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
849
40


Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
33

Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction.
Michael J Callahan, Christopher P Crum, Fabiola Medeiros, David W Kindelberger, Julia A Elvin, Judy E Garber, Colleen M Feltmate, Ross S Berkowitz, Michael G Muto. J Clin Oncol 2007
336
33


Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers.
Susan M Domchek, Tara M Friebel, Judy E Garber, Claudine Isaacs, Ellen Matloff, Rosalind Eeles, D Gareth Evans, Wendy Rubinstein, Christian F Singer, Stephen Rubin,[...]. Breast Cancer Res Treat 2010
45
29

Pathologic findings in prophylactic oophorectomy specimens in high-risk women.
Katherine Leeper, Rochelle Garcia, Elizabeth Swisher, Barbara Goff, Benjamin Greer, Pamela Paley. Gynecol Oncol 2002
190
29

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.
Mary-Claire King, Joan H Marks, Jessica B Mandell. Science 2003
29

Outcome of surveillance and prophylactic salpingo-oophorectomy in asymptomatic women at high risk for ovarian cancer.
Paul A M Meeuwissen, Caroline Seynaeve, Cecile T M Brekelmans, Hanne J Meijers-Heijboer, Jan G M Klijn, Curt W Burger. Gynecol Oncol 2005
68
29

Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy.
Julie D Lamb, Rochelle L Garcia, Barbara A Goff, Pamela J Paley, Elizabeth M Swisher. Am J Obstet Gynecol 2006
66
25

High rates of occult fallopian tube cancer diagnosed at prophylactic bilateral salpingo-oophorectomy.
Jane E Hirst, Gregory B Gard, Kirsty McIllroy, David Nevell, Michael Field. Int J Gynecol Cancer 2009
48
25


Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007
25

Support of the 'fallopian tube hypothesis' in a prospective series of risk-reducing salpingo-oophorectomy specimens.
Welmoed Reitsma, Geertruida H de Bock, Jan C Oosterwijk, Joost Bart, Harry Hollema, Marian J E Mourits. Eur J Cancer 2013
73
25

Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up.
R I Olivier, M van Beurden, M A C Lubsen, M A Rookus, T M Mooij, M J van de Vijver, L J van't Veer. Br J Cancer 2004
93
22

Incidental carcinomas in prophylactic specimens in BRCA1 and BRCA2 germ-line mutation carriers, with emphasis on fallopian tube lesions: report of 6 cases and review of the literature.
Maria L Carcangiu, Bernard Peissel, Barbara Pasini, Gianbattista Spatti, Paolo Radice, Siranoush Manoukian. Am J Surg Pathol 2006
94
22

The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.
Fabiola Medeiros, Michael G Muto, Yonghee Lee, Julia A Elvin, Michael J Callahan, Colleen Feltmate, Judy E Garber, Daniel W Cramer, Christopher P Crum. Am J Surg Pathol 2006
561
22

Risk-reducing surgery for ovarian cancer: outcomes in 300 surgeries suggest a low peritoneal primary risk.
D Gareth R Evans, Richard Clayton, Paul Donnai, Andrew Shenton, Fiona Lalloo. Eur J Hum Genet 2009
24
25

Microscopic and early-stage ovarian cancers in BRCA1/2 mutation carriers: building a model for early BRCA-associated tumorigenesis.
Melinda S Yates, Larissa A Meyer, Michael T Deavers, Molly S Daniels, Elizabeth R Keeler, Samuel C Mok, David M Gershenson, Karen H Lu. Cancer Prev Res (Phila) 2011
42
22

Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Murray Joseph Casey, Carrie Synder, Chhanda Bewtra, Steven A Narod, Patrice Watson, Henry T Lynch. Gynecol Oncol 2005
56
22

Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.
Amy P M Finch, Jan Lubinski, Pål Møller, Christian F Singer, Beth Karlan, Leigha Senter, Barry Rosen, Lovise Maehle, Parviz Ghadirian, Cezary Cybulski,[...]. J Clin Oncol 2014
342
22

Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy.
K H Lu, J E Garber, D W Cramer, W R Welch, J Niloff, D Schrag, R S Berkowitz, M G Muto. J Clin Oncol 2000
119
18

Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study.
Susan M Domchek, Tara M Friebel, Susan L Neuhausen, Theresa Wagner, Gareth Evans, Claudine Isaacs, Judy E Garber, Mary B Daly, Rosalind Eeles, Ellen Matloff,[...]. Lancet Oncol 2006
211
18

Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers.
Lauren Scheuer, Noah Kauff, Mark Robson, Bridget Kelly, Richard Barakat, Jaya Satagopan, Nathan Ellis, Martee Hensley, Jeff Boyd, Patrick Borgen,[...]. J Clin Oncol 2002
307
18

BRCA germline mutations in women with uterine serous carcinoma--still a debate.
Ofer Lavie, Alon Ben-Arie, Yakir Segev, Jonathan Faro, Frida Barak, Nir Haya, Ron Auslender, Ofer Gemer. Int J Gynecol Cancer 2010
48
18

Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status.
R Manchanda, A Abdelraheim, M Johnson, A N Rosenthal, E Benjamin, C Brunell, M Burnell, L Side, S Gessler, E Saridogan,[...]. BJOG 2011
74
18

Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers.
Mary S Beattie, Beth Crawford, Feng Lin, Eric Vittinghoff, John Ziegler. Genet Test Mol Biomarkers 2009
66
18

Prophylactic salpingo-oophorectomy in a series of 89 women carrying a BRCA1 or a BRCA2 mutation.
Fatima Laki, Youlia M Kirova, Pascale This, Corinne Plancher, Bernard Asselain, Xavier Sastre, Dominique Stoppa-Lyonnet, Remy Salmon. Cancer 2007
35
18

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998
14

Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers.
Amy Finch, Patricia Shaw, Barry Rosen, Joan Murphy, Steven A Narod, Terence J Colgan. Gynecol Oncol 2006
259
14

Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Timothy R Rebbeck, Tara Friebel, Theresa Wagner, Henry T Lynch, Judy E Garber, Mary B Daly, Claudine Isaacs, Olufunmilayo I Olopade, Susan L Neuhausen, Laura van 't Veer,[...]. J Clin Oncol 2005
268
14

Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers.
Andrea Eisen, Jan Lubinski, Jacek Gronwald, Pal Moller, Henry T Lynch, Jan Klijn, Charmaine Kim-Sing, Susan L Neuhausen, Lucy Gilbert, Parviz Ghadirian,[...]. J Natl Cancer Inst 2008
127
14


Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
Jaya M Satagopan, Jeff Boyd, Noah D Kauff, Mark Robson, Lauren Scheuer, Steven Narod, Kenneth Offit. Clin Cancer Res 2002
112
14

Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: a meta-analysis.
S Iodice, M Barile, N Rotmensz, I Feroce, B Bonanni, P Radice, L Bernard, P Maisonneuve, S Gandini. Eur J Cancer 2010
118
14

Surveillance of survivors: follow-up after risk-reducing salpingo-oophorectomy in BRCA 1/2 mutation carriers.
Jocelyn S Chapman, C Bethan Powell, Jane McLennan, Beth Crawford, Julie Mak, Nicola Stewart, Lee-May Chen. Gynecol Oncol 2011
32
14


Radical fimbriectomy: a reasonable temporary risk-reducing surgery for selected women with a germ line mutation of BRCA 1 or 2 genes? Rationale and preliminary development.
Eric Leblanc, Fabrice Narducci, Isabelle Farre, Jean-Philippe Peyrat, Sophie Taieb, Claude Adenis, Philippe Vennin. Gynecol Oncol 2011
55
14

Time to stop ovarian cancer screening in BRCA1/2 mutation carriers?
Nienke M van der Velde, Marian J E Mourits, Henriëtte J G Arts, Jacob de Vries, Beike K Leegte, Grieteke Dijkhuis, Jan C Oosterwijk, Geertruida H de Bock. Int J Cancer 2009
83
14

No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study.
B B J Hermsen, R I Olivier, R H M Verheijen, M van Beurden, J A de Hullu, L F Massuger, C W Burger, C T Brekelmans, M J Mourits, G H de Bock,[...]. Br J Cancer 2007
97
14

Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations.
Douglas A Levine, Peter A Argenta, Cindy J Yee, David S Marshall, Narciso Olvera, Faina Bogomolniy, Jamal A Rahaman, Mark E Robson, Kenneth Offit, Richard R Barakat,[...]. J Clin Oncol 2003
120
14

Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.
Saundra S Buys, Edward Partridge, Amanda Black, Christine C Johnson, Lois Lamerato, Claudine Isaacs, Douglas J Reding, Robert T Greenlee, Lance A Yokochi, Bruce Kessel,[...]. JAMA 2011
731
14

Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers.
Janice S Kwon, Anna Tinker, Gary Pansegrau, Jessica McAlpine, Melissa Housty, Mary McCullum, C Blake Gilks. Obstet Gynecol 2013
103
14

Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancers.
D G Evans, K N Gaarenstroom, D Stirling, A Shenton, L Maehle, A Dørum, M Steel, F Lalloo, J Apold, M E Porteous,[...]. J Med Genet 2009
82
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.